Cite
MLA Citation
Andres Forero et al.. “Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab.” Journal for immunotherapy of cancer, vol. 1, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100137790191.0x000007